0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pharmacokinetics Testing Service Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-5E15426
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pharmacokinetics Testing Service Market Research Report 2023
BUY CHAPTERS

Global Pharmacokinetics Testing Service Market Research Report 2025

Code: QYRE-Auto-5E15426
Report
May 2025
Pages:101
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pharmacokinetics Testing Service Market Size

The global market for Pharmacokinetics Testing Service was valued at US$ 370 million in the year 2024 and is projected to reach a revised size of US$ 610 million by 2031, growing at a CAGR of 7.5% during the forecast period.

Pharmacokinetics Testing Service Market

Pharmacokinetics Testing Service Market

The pharmacokinetics testing service market is expected to witness significant growth in the coming years. This can be attributed to the increasing demand for personalized medicine, rising prevalence of chronic diseases, and advancements in drug development and clinical trials.North America is expected to dominate the pharmacokinetics testing service market due to the presence of a well-established healthcare infrastructure, increasing R&D activities, and a large number of pharmaceutical companies in the region.Europe is also a significant market for pharmacokinetics testing services, driven by the presence of major pharmaceutical companies, increasing investments in drug development, and favorable government initiatives.The Asia Pacific region is expected to witness rapid growth in the pharmacokinetics testing service market due to the increasing outsourcing of drug development activities to countries like India and China, rising healthcare expenditure, and a large patient pool.The pharmacokinetics testing service market is highly fragmented, with the presence of numerous small and large players. However, a few major players dominate the market, accounting for a significant market share. These players have a strong presence in multiple regions and offer a wide range of pharmacokinetics testing services.The increasing focus on personalized medicine and targeted therapies presents significant opportunities for pharmacokinetics testing service providers. Personalized medicine requires precise pharmacokinetic data to determine the optimal drug dosage for individual patients.Technological advancements, such as the development of advanced analytical techniques and high-throughput screening methods, are expected to create new opportunities in the pharmacokinetics testing service market. These advancements enable faster and more accurate analysis of drug metabolism and pharmacokinetic parameters.The pharmacokinetics testing service market is subject to strict regulatory requirements, which can pose challenges for service providers. Compliance with regulatory guidelines and obtaining necessary approvals can be time-consuming and costly. Pharmacokinetics testing services can be expensive, especially for small and medium-sized pharmaceutical companies. The high cost of testing services can act as a barrier to market entry for some players and limit the adoption of these services.Overall, the pharmacokinetics testing service market is expected to grow significantly in the coming years, driven by factors such as the increasing demand for personalized medicine and advancements in drug development. However, challenges such as stringent regulatory requirements and high testing costs need to be addressed for the market to reach its full potential.
This report aims to provide a comprehensive presentation of the global market for Pharmacokinetics Testing Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmacokinetics Testing Service.
The Pharmacokinetics Testing Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmacokinetics Testing Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmacokinetics Testing Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Pharmacokinetics Testing Service Market Report

Report Metric Details
Report Name Pharmacokinetics Testing Service Market
Accounted market size in year US$ 370 million
Forecasted market size in 2031 US$ 610 million
CAGR 7.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Proteomics International, Labcorp, Pharmaron, Svar, NorthEast BioLab, BioAgilytix, Washington Biotechnology, Inc.(WBI), Eurofins BioPharma, Charles River, SCAS, Chimera, Phoenix WinNonlin, CD bioparticles, ACM Global Laboratories, WuXi AppTec, BioGenes, Pacific BioLabs, XenoTech, Medpace, SGS, CellCarta, Precision
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Pharmacokinetics Testing Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Pharmacokinetics Testing Service Market growing?

Ans: The Pharmacokinetics Testing Service Market witnessing a CAGR of 7.5% during the forecast period 2025-2031.

What is the Pharmacokinetics Testing Service Market size in 2031?

Ans: The Pharmacokinetics Testing Service Market size in 2031 will be US$ 610 million.

Who are the main players in the Pharmacokinetics Testing Service Market report?

Ans: The main players in the Pharmacokinetics Testing Service Market are Proteomics International, Labcorp, Pharmaron, Svar, NorthEast BioLab, BioAgilytix, Washington Biotechnology, Inc.(WBI), Eurofins BioPharma, Charles River, SCAS, Chimera, Phoenix WinNonlin, CD bioparticles, ACM Global Laboratories, WuXi AppTec, BioGenes, Pacific BioLabs, XenoTech, Medpace, SGS, CellCarta, Precision

What are the Application segmentation covered in the Pharmacokinetics Testing Service Market report?

Ans: The Applications covered in the Pharmacokinetics Testing Service Market report are Drug Development, Clinical Trials, Veterinary Medicine, Other

What are the Type segmentation covered in the Pharmacokinetics Testing Service Market report?

Ans: The Types covered in the Pharmacokinetics Testing Service Market report are Microscale Thermophoresis, Mass Spectrometry

Recommended Reports

Pharmaceutical Testing Services

Drug Testing and Analysis

Medical and Biomedical Services

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmacokinetics Testing Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Microscale Thermophoresis
1.2.3 Mass Spectrometry
1.3 Market by Application
1.3.1 Global Pharmacokinetics Testing Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Drug Development
1.3.3 Clinical Trials
1.3.4 Veterinary Medicine
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmacokinetics Testing Service Market Perspective (2020-2031)
2.2 Global Pharmacokinetics Testing Service Growth Trends by Region
2.2.1 Global Pharmacokinetics Testing Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Pharmacokinetics Testing Service Historic Market Size by Region (2020-2025)
2.2.3 Pharmacokinetics Testing Service Forecasted Market Size by Region (2026-2031)
2.3 Pharmacokinetics Testing Service Market Dynamics
2.3.1 Pharmacokinetics Testing Service Industry Trends
2.3.2 Pharmacokinetics Testing Service Market Drivers
2.3.3 Pharmacokinetics Testing Service Market Challenges
2.3.4 Pharmacokinetics Testing Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmacokinetics Testing Service Players by Revenue
3.1.1 Global Top Pharmacokinetics Testing Service Players by Revenue (2020-2025)
3.1.2 Global Pharmacokinetics Testing Service Revenue Market Share by Players (2020-2025)
3.2 Global Pharmacokinetics Testing Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pharmacokinetics Testing Service Revenue
3.4 Global Pharmacokinetics Testing Service Market Concentration Ratio
3.4.1 Global Pharmacokinetics Testing Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmacokinetics Testing Service Revenue in 2024
3.5 Global Key Players of Pharmacokinetics Testing Service Head office and Area Served
3.6 Global Key Players of Pharmacokinetics Testing Service, Product and Application
3.7 Global Key Players of Pharmacokinetics Testing Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmacokinetics Testing Service Breakdown Data by Type
4.1 Global Pharmacokinetics Testing Service Historic Market Size by Type (2020-2025)
4.2 Global Pharmacokinetics Testing Service Forecasted Market Size by Type (2026-2031)
5 Pharmacokinetics Testing Service Breakdown Data by Application
5.1 Global Pharmacokinetics Testing Service Historic Market Size by Application (2020-2025)
5.2 Global Pharmacokinetics Testing Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Pharmacokinetics Testing Service Market Size (2020-2031)
6.2 North America Pharmacokinetics Testing Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Pharmacokinetics Testing Service Market Size by Country (2020-2025)
6.4 North America Pharmacokinetics Testing Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmacokinetics Testing Service Market Size (2020-2031)
7.2 Europe Pharmacokinetics Testing Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Pharmacokinetics Testing Service Market Size by Country (2020-2025)
7.4 Europe Pharmacokinetics Testing Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmacokinetics Testing Service Market Size (2020-2031)
8.2 Asia-Pacific Pharmacokinetics Testing Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Pharmacokinetics Testing Service Market Size by Region (2020-2025)
8.4 Asia-Pacific Pharmacokinetics Testing Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmacokinetics Testing Service Market Size (2020-2031)
9.2 Latin America Pharmacokinetics Testing Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Pharmacokinetics Testing Service Market Size by Country (2020-2025)
9.4 Latin America Pharmacokinetics Testing Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmacokinetics Testing Service Market Size (2020-2031)
10.2 Middle East & Africa Pharmacokinetics Testing Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Pharmacokinetics Testing Service Market Size by Country (2020-2025)
10.4 Middle East & Africa Pharmacokinetics Testing Service Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Proteomics International
11.1.1 Proteomics International Company Details
11.1.2 Proteomics International Business Overview
11.1.3 Proteomics International Pharmacokinetics Testing Service Introduction
11.1.4 Proteomics International Revenue in Pharmacokinetics Testing Service Business (2020-2025)
11.1.5 Proteomics International Recent Development
11.2 Labcorp
11.2.1 Labcorp Company Details
11.2.2 Labcorp Business Overview
11.2.3 Labcorp Pharmacokinetics Testing Service Introduction
11.2.4 Labcorp Revenue in Pharmacokinetics Testing Service Business (2020-2025)
11.2.5 Labcorp Recent Development
11.3 Pharmaron
11.3.1 Pharmaron Company Details
11.3.2 Pharmaron Business Overview
11.3.3 Pharmaron Pharmacokinetics Testing Service Introduction
11.3.4 Pharmaron Revenue in Pharmacokinetics Testing Service Business (2020-2025)
11.3.5 Pharmaron Recent Development
11.4 Svar
11.4.1 Svar Company Details
11.4.2 Svar Business Overview
11.4.3 Svar Pharmacokinetics Testing Service Introduction
11.4.4 Svar Revenue in Pharmacokinetics Testing Service Business (2020-2025)
11.4.5 Svar Recent Development
11.5 NorthEast BioLab
11.5.1 NorthEast BioLab Company Details
11.5.2 NorthEast BioLab Business Overview
11.5.3 NorthEast BioLab Pharmacokinetics Testing Service Introduction
11.5.4 NorthEast BioLab Revenue in Pharmacokinetics Testing Service Business (2020-2025)
11.5.5 NorthEast BioLab Recent Development
11.6 BioAgilytix
11.6.1 BioAgilytix Company Details
11.6.2 BioAgilytix Business Overview
11.6.3 BioAgilytix Pharmacokinetics Testing Service Introduction
11.6.4 BioAgilytix Revenue in Pharmacokinetics Testing Service Business (2020-2025)
11.6.5 BioAgilytix Recent Development
11.7 Washington Biotechnology, Inc.(WBI)
11.7.1 Washington Biotechnology, Inc.(WBI) Company Details
11.7.2 Washington Biotechnology, Inc.(WBI) Business Overview
11.7.3 Washington Biotechnology, Inc.(WBI) Pharmacokinetics Testing Service Introduction
11.7.4 Washington Biotechnology, Inc.(WBI) Revenue in Pharmacokinetics Testing Service Business (2020-2025)
11.7.5 Washington Biotechnology, Inc.(WBI) Recent Development
11.8 Eurofins BioPharma
11.8.1 Eurofins BioPharma Company Details
11.8.2 Eurofins BioPharma Business Overview
11.8.3 Eurofins BioPharma Pharmacokinetics Testing Service Introduction
11.8.4 Eurofins BioPharma Revenue in Pharmacokinetics Testing Service Business (2020-2025)
11.8.5 Eurofins BioPharma Recent Development
11.9 Charles River
11.9.1 Charles River Company Details
11.9.2 Charles River Business Overview
11.9.3 Charles River Pharmacokinetics Testing Service Introduction
11.9.4 Charles River Revenue in Pharmacokinetics Testing Service Business (2020-2025)
11.9.5 Charles River Recent Development
11.10 SCAS
11.10.1 SCAS Company Details
11.10.2 SCAS Business Overview
11.10.3 SCAS Pharmacokinetics Testing Service Introduction
11.10.4 SCAS Revenue in Pharmacokinetics Testing Service Business (2020-2025)
11.10.5 SCAS Recent Development
11.11 Chimera
11.11.1 Chimera Company Details
11.11.2 Chimera Business Overview
11.11.3 Chimera Pharmacokinetics Testing Service Introduction
11.11.4 Chimera Revenue in Pharmacokinetics Testing Service Business (2020-2025)
11.11.5 Chimera Recent Development
11.12 Phoenix WinNonlin
11.12.1 Phoenix WinNonlin Company Details
11.12.2 Phoenix WinNonlin Business Overview
11.12.3 Phoenix WinNonlin Pharmacokinetics Testing Service Introduction
11.12.4 Phoenix WinNonlin Revenue in Pharmacokinetics Testing Service Business (2020-2025)
11.12.5 Phoenix WinNonlin Recent Development
11.13 CD bioparticles
11.13.1 CD bioparticles Company Details
11.13.2 CD bioparticles Business Overview
11.13.3 CD bioparticles Pharmacokinetics Testing Service Introduction
11.13.4 CD bioparticles Revenue in Pharmacokinetics Testing Service Business (2020-2025)
11.13.5 CD bioparticles Recent Development
11.14 ACM Global Laboratories
11.14.1 ACM Global Laboratories Company Details
11.14.2 ACM Global Laboratories Business Overview
11.14.3 ACM Global Laboratories Pharmacokinetics Testing Service Introduction
11.14.4 ACM Global Laboratories Revenue in Pharmacokinetics Testing Service Business (2020-2025)
11.14.5 ACM Global Laboratories Recent Development
11.15 WuXi AppTec
11.15.1 WuXi AppTec Company Details
11.15.2 WuXi AppTec Business Overview
11.15.3 WuXi AppTec Pharmacokinetics Testing Service Introduction
11.15.4 WuXi AppTec Revenue in Pharmacokinetics Testing Service Business (2020-2025)
11.15.5 WuXi AppTec Recent Development
11.16 BioGenes
11.16.1 BioGenes Company Details
11.16.2 BioGenes Business Overview
11.16.3 BioGenes Pharmacokinetics Testing Service Introduction
11.16.4 BioGenes Revenue in Pharmacokinetics Testing Service Business (2020-2025)
11.16.5 BioGenes Recent Development
11.17 Pacific BioLabs
11.17.1 Pacific BioLabs Company Details
11.17.2 Pacific BioLabs Business Overview
11.17.3 Pacific BioLabs Pharmacokinetics Testing Service Introduction
11.17.4 Pacific BioLabs Revenue in Pharmacokinetics Testing Service Business (2020-2025)
11.17.5 Pacific BioLabs Recent Development
11.18 XenoTech
11.18.1 XenoTech Company Details
11.18.2 XenoTech Business Overview
11.18.3 XenoTech Pharmacokinetics Testing Service Introduction
11.18.4 XenoTech Revenue in Pharmacokinetics Testing Service Business (2020-2025)
11.18.5 XenoTech Recent Development
11.19 Medpace
11.19.1 Medpace Company Details
11.19.2 Medpace Business Overview
11.19.3 Medpace Pharmacokinetics Testing Service Introduction
11.19.4 Medpace Revenue in Pharmacokinetics Testing Service Business (2020-2025)
11.19.5 Medpace Recent Development
11.20 SGS
11.20.1 SGS Company Details
11.20.2 SGS Business Overview
11.20.3 SGS Pharmacokinetics Testing Service Introduction
11.20.4 SGS Revenue in Pharmacokinetics Testing Service Business (2020-2025)
11.20.5 SGS Recent Development
11.21 CellCarta
11.21.1 CellCarta Company Details
11.21.2 CellCarta Business Overview
11.21.3 CellCarta Pharmacokinetics Testing Service Introduction
11.21.4 CellCarta Revenue in Pharmacokinetics Testing Service Business (2020-2025)
11.21.5 CellCarta Recent Development
11.22 Precision
11.22.1 Precision Company Details
11.22.2 Precision Business Overview
11.22.3 Precision Pharmacokinetics Testing Service Introduction
11.22.4 Precision Revenue in Pharmacokinetics Testing Service Business (2020-2025)
11.22.5 Precision Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Pharmacokinetics Testing Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Microscale Thermophoresis
 Table 3. Key Players of Mass Spectrometry
 Table 4. Global Pharmacokinetics Testing Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Pharmacokinetics Testing Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Pharmacokinetics Testing Service Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Pharmacokinetics Testing Service Market Share by Region (2020-2025)
 Table 8. Global Pharmacokinetics Testing Service Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Pharmacokinetics Testing Service Market Share by Region (2026-2031)
 Table 10. Pharmacokinetics Testing Service Market Trends
 Table 11. Pharmacokinetics Testing Service Market Drivers
 Table 12. Pharmacokinetics Testing Service Market Challenges
 Table 13. Pharmacokinetics Testing Service Market Restraints
 Table 14. Global Pharmacokinetics Testing Service Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Pharmacokinetics Testing Service Market Share by Players (2020-2025)
 Table 16. Global Top Pharmacokinetics Testing Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacokinetics Testing Service as of 2024)
 Table 17. Ranking of Global Top Pharmacokinetics Testing Service Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Pharmacokinetics Testing Service Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Pharmacokinetics Testing Service, Headquarters and Area Served
 Table 20. Global Key Players of Pharmacokinetics Testing Service, Product and Application
 Table 21. Global Key Players of Pharmacokinetics Testing Service, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Pharmacokinetics Testing Service Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Pharmacokinetics Testing Service Revenue Market Share by Type (2020-2025)
 Table 25. Global Pharmacokinetics Testing Service Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Pharmacokinetics Testing Service Revenue Market Share by Type (2026-2031)
 Table 27. Global Pharmacokinetics Testing Service Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Pharmacokinetics Testing Service Revenue Market Share by Application (2020-2025)
 Table 29. Global Pharmacokinetics Testing Service Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Pharmacokinetics Testing Service Revenue Market Share by Application (2026-2031)
 Table 31. North America Pharmacokinetics Testing Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Pharmacokinetics Testing Service Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Pharmacokinetics Testing Service Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Pharmacokinetics Testing Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Pharmacokinetics Testing Service Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Pharmacokinetics Testing Service Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Pharmacokinetics Testing Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Pharmacokinetics Testing Service Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Pharmacokinetics Testing Service Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Pharmacokinetics Testing Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Pharmacokinetics Testing Service Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Pharmacokinetics Testing Service Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Pharmacokinetics Testing Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Pharmacokinetics Testing Service Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Pharmacokinetics Testing Service Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Proteomics International Company Details
 Table 47. Proteomics International Business Overview
 Table 48. Proteomics International Pharmacokinetics Testing Service Product
 Table 49. Proteomics International Revenue in Pharmacokinetics Testing Service Business (2020-2025) & (US$ Million)
 Table 50. Proteomics International Recent Development
 Table 51. Labcorp Company Details
 Table 52. Labcorp Business Overview
 Table 53. Labcorp Pharmacokinetics Testing Service Product
 Table 54. Labcorp Revenue in Pharmacokinetics Testing Service Business (2020-2025) & (US$ Million)
 Table 55. Labcorp Recent Development
 Table 56. Pharmaron Company Details
 Table 57. Pharmaron Business Overview
 Table 58. Pharmaron Pharmacokinetics Testing Service Product
 Table 59. Pharmaron Revenue in Pharmacokinetics Testing Service Business (2020-2025) & (US$ Million)
 Table 60. Pharmaron Recent Development
 Table 61. Svar Company Details
 Table 62. Svar Business Overview
 Table 63. Svar Pharmacokinetics Testing Service Product
 Table 64. Svar Revenue in Pharmacokinetics Testing Service Business (2020-2025) & (US$ Million)
 Table 65. Svar Recent Development
 Table 66. NorthEast BioLab Company Details
 Table 67. NorthEast BioLab Business Overview
 Table 68. NorthEast BioLab Pharmacokinetics Testing Service Product
 Table 69. NorthEast BioLab Revenue in Pharmacokinetics Testing Service Business (2020-2025) & (US$ Million)
 Table 70. NorthEast BioLab Recent Development
 Table 71. BioAgilytix Company Details
 Table 72. BioAgilytix Business Overview
 Table 73. BioAgilytix Pharmacokinetics Testing Service Product
 Table 74. BioAgilytix Revenue in Pharmacokinetics Testing Service Business (2020-2025) & (US$ Million)
 Table 75. BioAgilytix Recent Development
 Table 76. Washington Biotechnology, Inc.(WBI) Company Details
 Table 77. Washington Biotechnology, Inc.(WBI) Business Overview
 Table 78. Washington Biotechnology, Inc.(WBI) Pharmacokinetics Testing Service Product
 Table 79. Washington Biotechnology, Inc.(WBI) Revenue in Pharmacokinetics Testing Service Business (2020-2025) & (US$ Million)
 Table 80. Washington Biotechnology, Inc.(WBI) Recent Development
 Table 81. Eurofins BioPharma Company Details
 Table 82. Eurofins BioPharma Business Overview
 Table 83. Eurofins BioPharma Pharmacokinetics Testing Service Product
 Table 84. Eurofins BioPharma Revenue in Pharmacokinetics Testing Service Business (2020-2025) & (US$ Million)
 Table 85. Eurofins BioPharma Recent Development
 Table 86. Charles River Company Details
 Table 87. Charles River Business Overview
 Table 88. Charles River Pharmacokinetics Testing Service Product
 Table 89. Charles River Revenue in Pharmacokinetics Testing Service Business (2020-2025) & (US$ Million)
 Table 90. Charles River Recent Development
 Table 91. SCAS Company Details
 Table 92. SCAS Business Overview
 Table 93. SCAS Pharmacokinetics Testing Service Product
 Table 94. SCAS Revenue in Pharmacokinetics Testing Service Business (2020-2025) & (US$ Million)
 Table 95. SCAS Recent Development
 Table 96. Chimera Company Details
 Table 97. Chimera Business Overview
 Table 98. Chimera Pharmacokinetics Testing Service Product
 Table 99. Chimera Revenue in Pharmacokinetics Testing Service Business (2020-2025) & (US$ Million)
 Table 100. Chimera Recent Development
 Table 101. Phoenix WinNonlin Company Details
 Table 102. Phoenix WinNonlin Business Overview
 Table 103. Phoenix WinNonlin Pharmacokinetics Testing Service Product
 Table 104. Phoenix WinNonlin Revenue in Pharmacokinetics Testing Service Business (2020-2025) & (US$ Million)
 Table 105. Phoenix WinNonlin Recent Development
 Table 106. CD bioparticles Company Details
 Table 107. CD bioparticles Business Overview
 Table 108. CD bioparticles Pharmacokinetics Testing Service Product
 Table 109. CD bioparticles Revenue in Pharmacokinetics Testing Service Business (2020-2025) & (US$ Million)
 Table 110. CD bioparticles Recent Development
 Table 111. ACM Global Laboratories Company Details
 Table 112. ACM Global Laboratories Business Overview
 Table 113. ACM Global Laboratories Pharmacokinetics Testing Service Product
 Table 114. ACM Global Laboratories Revenue in Pharmacokinetics Testing Service Business (2020-2025) & (US$ Million)
 Table 115. ACM Global Laboratories Recent Development
 Table 116. WuXi AppTec Company Details
 Table 117. WuXi AppTec Business Overview
 Table 118. WuXi AppTec Pharmacokinetics Testing Service Product
 Table 119. WuXi AppTec Revenue in Pharmacokinetics Testing Service Business (2020-2025) & (US$ Million)
 Table 120. WuXi AppTec Recent Development
 Table 121. BioGenes Company Details
 Table 122. BioGenes Business Overview
 Table 123. BioGenes Pharmacokinetics Testing Service Product
 Table 124. BioGenes Revenue in Pharmacokinetics Testing Service Business (2020-2025) & (US$ Million)
 Table 125. BioGenes Recent Development
 Table 126. Pacific BioLabs Company Details
 Table 127. Pacific BioLabs Business Overview
 Table 128. Pacific BioLabs Pharmacokinetics Testing Service Product
 Table 129. Pacific BioLabs Revenue in Pharmacokinetics Testing Service Business (2020-2025) & (US$ Million)
 Table 130. Pacific BioLabs Recent Development
 Table 131. XenoTech Company Details
 Table 132. XenoTech Business Overview
 Table 133. XenoTech Pharmacokinetics Testing Service Product
 Table 134. XenoTech Revenue in Pharmacokinetics Testing Service Business (2020-2025) & (US$ Million)
 Table 135. XenoTech Recent Development
 Table 136. Medpace Company Details
 Table 137. Medpace Business Overview
 Table 138. Medpace Pharmacokinetics Testing Service Product
 Table 139. Medpace Revenue in Pharmacokinetics Testing Service Business (2020-2025) & (US$ Million)
 Table 140. Medpace Recent Development
 Table 141. SGS Company Details
 Table 142. SGS Business Overview
 Table 143. SGS Pharmacokinetics Testing Service Product
 Table 144. SGS Revenue in Pharmacokinetics Testing Service Business (2020-2025) & (US$ Million)
 Table 145. SGS Recent Development
 Table 146. CellCarta Company Details
 Table 147. CellCarta Business Overview
 Table 148. CellCarta Pharmacokinetics Testing Service Product
 Table 149. CellCarta Revenue in Pharmacokinetics Testing Service Business (2020-2025) & (US$ Million)
 Table 150. CellCarta Recent Development
 Table 151. Precision Company Details
 Table 152. Precision Business Overview
 Table 153. Precision Pharmacokinetics Testing Service Product
 Table 154. Precision Revenue in Pharmacokinetics Testing Service Business (2020-2025) & (US$ Million)
 Table 155. Precision Recent Development
 Table 156. Research Programs/Design for This Report
 Table 157. Key Data Information from Secondary Sources
 Table 158. Key Data Information from Primary Sources
 Table 159. Authors List of This Report


List of Figures
 Figure 1. Pharmacokinetics Testing Service Picture
 Figure 2. Global Pharmacokinetics Testing Service Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pharmacokinetics Testing Service Market Share by Type: 2024 VS 2031
 Figure 4. Microscale Thermophoresis Features
 Figure 5. Mass Spectrometry Features
 Figure 6. Global Pharmacokinetics Testing Service Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Pharmacokinetics Testing Service Market Share by Application: 2024 VS 2031
 Figure 8. Drug Development Case Studies
 Figure 9. Clinical Trials Case Studies
 Figure 10. Veterinary Medicine Case Studies
 Figure 11. Other Case Studies
 Figure 12. Pharmacokinetics Testing Service Report Years Considered
 Figure 13. Global Pharmacokinetics Testing Service Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Pharmacokinetics Testing Service Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Pharmacokinetics Testing Service Market Share by Region: 2024 VS 2031
 Figure 16. Global Pharmacokinetics Testing Service Market Share by Players in 2024
 Figure 17. Global Top Pharmacokinetics Testing Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacokinetics Testing Service as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Pharmacokinetics Testing Service Revenue in 2024
 Figure 19. North America Pharmacokinetics Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Pharmacokinetics Testing Service Market Share by Country (2020-2031)
 Figure 21. United States Pharmacokinetics Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Pharmacokinetics Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Pharmacokinetics Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Pharmacokinetics Testing Service Market Share by Country (2020-2031)
 Figure 25. Germany Pharmacokinetics Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Pharmacokinetics Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Pharmacokinetics Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Pharmacokinetics Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Pharmacokinetics Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Pharmacokinetics Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Pharmacokinetics Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Pharmacokinetics Testing Service Market Share by Region (2020-2031)
 Figure 33. China Pharmacokinetics Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Pharmacokinetics Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Pharmacokinetics Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Pharmacokinetics Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Pharmacokinetics Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Pharmacokinetics Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Pharmacokinetics Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Pharmacokinetics Testing Service Market Share by Country (2020-2031)
 Figure 41. Mexico Pharmacokinetics Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Pharmacokinetics Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Pharmacokinetics Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Pharmacokinetics Testing Service Market Share by Country (2020-2031)
 Figure 45. Turkey Pharmacokinetics Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Pharmacokinetics Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Pharmacokinetics Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Proteomics International Revenue Growth Rate in Pharmacokinetics Testing Service Business (2020-2025)
 Figure 49. Labcorp Revenue Growth Rate in Pharmacokinetics Testing Service Business (2020-2025)
 Figure 50. Pharmaron Revenue Growth Rate in Pharmacokinetics Testing Service Business (2020-2025)
 Figure 51. Svar Revenue Growth Rate in Pharmacokinetics Testing Service Business (2020-2025)
 Figure 52. NorthEast BioLab Revenue Growth Rate in Pharmacokinetics Testing Service Business (2020-2025)
 Figure 53. BioAgilytix Revenue Growth Rate in Pharmacokinetics Testing Service Business (2020-2025)
 Figure 54. Washington Biotechnology, Inc.(WBI) Revenue Growth Rate in Pharmacokinetics Testing Service Business (2020-2025)
 Figure 55. Eurofins BioPharma Revenue Growth Rate in Pharmacokinetics Testing Service Business (2020-2025)
 Figure 56. Charles River Revenue Growth Rate in Pharmacokinetics Testing Service Business (2020-2025)
 Figure 57. SCAS Revenue Growth Rate in Pharmacokinetics Testing Service Business (2020-2025)
 Figure 58. Chimera Revenue Growth Rate in Pharmacokinetics Testing Service Business (2020-2025)
 Figure 59. Phoenix WinNonlin Revenue Growth Rate in Pharmacokinetics Testing Service Business (2020-2025)
 Figure 60. CD bioparticles Revenue Growth Rate in Pharmacokinetics Testing Service Business (2020-2025)
 Figure 61. ACM Global Laboratories Revenue Growth Rate in Pharmacokinetics Testing Service Business (2020-2025)
 Figure 62. WuXi AppTec Revenue Growth Rate in Pharmacokinetics Testing Service Business (2020-2025)
 Figure 63. BioGenes Revenue Growth Rate in Pharmacokinetics Testing Service Business (2020-2025)
 Figure 64. Pacific BioLabs Revenue Growth Rate in Pharmacokinetics Testing Service Business (2020-2025)
 Figure 65. XenoTech Revenue Growth Rate in Pharmacokinetics Testing Service Business (2020-2025)
 Figure 66. Medpace Revenue Growth Rate in Pharmacokinetics Testing Service Business (2020-2025)
 Figure 67. SGS Revenue Growth Rate in Pharmacokinetics Testing Service Business (2020-2025)
 Figure 68. CellCarta Revenue Growth Rate in Pharmacokinetics Testing Service Business (2020-2025)
 Figure 69. Precision Revenue Growth Rate in Pharmacokinetics Testing Service Business (2020-2025)
 Figure 70. Bottom-up and Top-down Approaches for This Report
 Figure 71. Data Triangulation
 Figure 72. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS